Silk Road Medical (SILK) Stock Price, News & Analysis

Company Overview

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

Key Stats

• Today's Range: $27.49 to $27.49
• 50-Day Range: $27.01 to $27.50
• 52-Week Range: $6.08 to $27.51
• Volume: N/A
• Average Volume: 1.20 million shs
• Market Capitalization: $1.12 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SILK Stock Analysis - Frequently Asked Questions

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) issued its quarterly earnings results on Wednesday, August, 7th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.38) by $0.04. The company's quarterly revenue was up 13.0% compared to the same quarter last year.

When did Silk Road Medical IPO?

Silk Road Medical (SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Silk Road Medical investors own include Tesla (TSLA), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Alphabet (GOOG).

Company Calendar

• Last Earnings: 8/07/2024
• Today: 7/19/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SILK
• CIK: 1397702
• Web: www.silkroadmed.com
• Phone: (408) 720-9002
• Fax: 408-720-9013
• Employees: 410
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($1.37)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$55.74 million
• Net Margins: -29.53%
• Pretax Margin: -29.53%
• Return on Equity: -37.30%
• Return on Assets: -21.57%

Debt

• Debt-to-Equity Ratio: 0.49
• Current Ratio: 7.63
• Quick Ratio: 6.69

Sales & Book Value

• Annual Sales: $177.13 million
• Price / Sales: 6.31
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.88 per share
• Price / Book: 7.09

Miscellaneous

• Outstanding Shares: 40,630,000
• Free Float: 37,906,000
• Market Cap: $1.12 billion
• Optionable: Optionable
• Beta: 1.53